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Background
The evidence for therapy in autoinflammatory diseases
is limited. There are few randomized controlled trials or
disease registries.
Aim
To evaluate the response to treatment of autoinflamma-
tory diseases based on data of an international registry.
Methods
A web-based registry collecting baseline and clinical
information of autoinflammatory diseases was located at
the member area of the PRINTO website (www.printo.
it). Participating hospitals included pediatric rheumatol-
ogy centers of the PRINTO network and adult centers
with a specific interest in autoinflammatory diseases.
Data was collected on Blau’s syndrome, Behçet’s disease,
CAPS, CRMO, DIRA, FMF, MKD, NLRP12-mediated
periodic fever, PAPA, PFAPA TRAPS and undefined
periodic fevers. In total, 704 patients were included in
this retrospective study on therapy.
Results
NSAIDs and steroids were beneficial in most diseases.
Anakinra induced a complete response in 70% of 40
treated CAPS patients, 82% of 28 TRAPS patients and
in both DIRA patients. Furthermore, it was beneficial in
80% of 10 MKD patients. Etanercept was completely
effective in all 6 Behçet patients, 34% of 32 TRAPS
patients and 13% of 8 MKD patients and partially effec-
tive in 53% of TRAPS and 38% of MKD patients. Col-
chicine was beneficial in approximately 95% of 131 FMF
and 18 Behçet patients, although the complete response
rate was just 56% and 22%, respectively. For PFAPA
syndrome, corticosteroids aborted the attacks in 78% of
113 patients.
Conclusion
The results were compared to the literature. These com-
bined findings could serve as a base for therapeutic
guidelines and identify candidate drugs for future thera-
peutic trials.
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